Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Pipeline
Interphex Showcase 2010.

Pharmaceutical Technology
Volume 34, Issue 4, pp. 128-135

MANUFACTURING EQUIPMENT & SUPPLIES



Sanitary ball valve
Lee Industries's T-316 stainless-steel highly sanitary-ball valve meets the qualifications of the pharmaceutical industry. Rigid corrosion-resistant and solid construction provides reliability under extreme conditions. A simple fast-breakdown design helps reduce cleanup and maintenance costs. Lee Industries, Philipsburg, PA http://www.leeind.com/ tel. 814.342.0461



Fluid-path assemblies
One-Touch single-use fluid-path assemblies are designed for secure fluid transfer in critical biopharmaceutical processing applications. The products can be customized to end-user requirements and include combinations of connectivity, tubing, and other components. Fluid paths can be integrated with filter capsules in various surface areas, end-connection configurations, and media. Meissner Filtration Products, Camarillo, CA http://www.meissner.com/ tel. 805.388.9911



Culturing set
SGM's DriAmp biological-indicator culturing set features Releasat medium and is designed for high-temperature, direct-air exposure or submersion in nonwater-based solutions. The DriAmp BI is a 1-mL, snap-top glass ampul containing inoculated silica. The Releasat medium provides a reduced incubation time of 72 h. A color change indicates positive test results. SGM Biotech, Inc., Bozeman, MT http://www.sgmbiotech.com/ tel. 406.585.9535



Visual inspection system
Eisai Machinery USA offers semiautomatic, semimanual, and manual VIS visual inspection systems. Eisai provides validation expertise to help implement VIS 1000 semiautomatic inspection machines. The company also provides a program of continuous service and technical support for its clients. The program monitors clients' machines to reduce downtime and improve production-line efficiency. Eisai Machinery USA, Hackensack, NJ http://www.eisaiusa.com/ tel.201.746.2111


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here